Alcresta Therapeutics Announces Enrollment of First Patient in Clinical Trial Evaluating Use of Relizorb in Pancreatitis Patients at Massachusetts General Hospital
Alcresta Therapeutics宣佈在馬薩諸塞州總醫院招募首位參與者,開展評估Relizorb在胰腺炎患者中使用的臨牀試驗。
Alcresta Therapeutics Announces Enrollment of First Patient in Clinical Trial Evaluating Use of Relizorb in Pancreatitis Patients at Massachusetts General Hospital
Alcresta Therapeutics宣佈在馬薩諸塞州總醫院招募首位參與者,開展評估Relizorb在胰腺炎患者中使用的臨牀試驗。
使用瀏覽器的分享功能,分享給你的好友吧
- 没有更多了 -